The trouble with neuralgic amyotrophy

Practical Neurology

Volumn 6, Issue 5, 2006, Pages 298-307

  Van Alfen, Nens ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANALGESIC AGENT; CARBAMAZEPINE; CORTICOSTEROID; DICLOFENAC; GABAPENTIN; LONG ACTING DRUG; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PLACEBO; PREDNISONE;

ACUTE PHASE RESPONSE; CLINICAL FEATURE; CLINICAL TRIAL; DIFFERENTIAL DIAGNOSIS; DRUG MEGADOSE; ELECTROMYOGRAM; FASCICULATION; HUMAN; LABORATORY DIAGNOSIS; MOTOR NEURON DISEASE; NEUROPATHIC PAIN; PAIN; PAIN ASSESSMENT; PHYSICAL EXAMINATION; PHYSIOTHERAPY; REHABILITATION CARE; REVIEW; SENSORY DYSFUNCTION; SHOULDER HAND SYNDROME; SHOULDER PAIN; SLOW RELEASE FORMULATION; SYMPTOMATOLOGY;

EID: 33749022231     PISSN: 14747758     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.2006.101261     Document Type: Review

References (8)

1. van Alfen N, van Engelen BGM. The clinical spectrum of neuralgic amyotrophy in 246 cases. Brain 2006;129:438-50.
2. Kuhlenbaumer G, Hannibal MC, Nelis E, et al. Mutations in SEPT9 cause hereditary neuralgic amyotrophy. Nat Genet 2005;37:1044-6.
3. MacDonald BK, Cockerell OC, Sander JW, et al. The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK. Brain 2000;123:665-76.
4. Beghi E, Kurland LT, Mulder DW, et al. Brachial plexus neuropathy in the population of Rochester, Minnesota, 1970-1981. Ann Neurol 1985;18:320-3.
5. Seror P. Isolated sensory manifestations in neuralgic amyotrophy: report of eight cases. Muscle Nerve 2004;29:134-8.
6. Terry GC, Chopp TM. Functional anatomy of the shoulder. J Athl Train 2000;35:248-55.
7. van Alfen N. The neuralgic amyotrophy consultation. J Neurol (in press).
8. Willbourn AJ. Brachial plexus lesions. In: Dyck PJ, Thomas PK (eds). Peripheral neuropathy. Philadelphia: Elsevier Saunders, 2005:1339-73.